Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALPHEE: Celivarone for prevention of ICD interventions
NCT00993382Phase 2Completed
- Sponsor
- Sanofi
- Start
- Sep 2009
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 26
01
Overview
A Phase 2 trial of celivarone in ventricular arrhythmia (VA), sponsored by Sanofi. Started Sep 2009; status: completed.
02
Drugs
celivarone
03
Conditions
ventricular arrhythmia (VA)
Beyond the preview
Go deeper on NCT00993382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00993382.